Notice of Closed Meeting, 2226-2227 [2019-01211]

Download as PDF 2226 Federal Register / Vol. 84, No. 25 / Wednesday, February 6, 2019 / Notices received, may be obtained by contacting Donna Lee at (202) 523–5800 or email: omd@fmc.gov. SUPPLEMENTARY INFORMATION: amozie on DSK3GDR082PROD with NOTICES1 Request for Comments The Federal Maritime Commission, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to comment on the continuing information collection listed in this notice, as required by the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Comments submitted in response to this notice will be included or summarized in our request for Office of Management and Budget approval of the relevant information collection. All comments are part of the public record and subject to disclosure. Please do not include any confidential or inappropriate material in your comments. We invite comments on: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Information Collection Open for Comment Title: 46 CFR 515—Licensing, Financial Responsibility Requirements, and General Duties for Ocean Transportation Intermediaries and Related Forms. OMB Approval Number: 3072–0018 (Expires March 31, 2019). Abstract: The Shipping Act of 1984 (the ‘‘Act’’), 46 U.S.C. 40101–41309 (2006), as modified by Public Law 105– 258 (The Ocean Shipping Reform Act of 1998) and Section 424 of Public Law 105–383 (The Coast Guard Authorization Act of 1998), provides that no person in the United States may act as an ocean transportation intermediary (OTI) unless that person holds a license issued by the Commission. The Commission shall issue an OTI license to any person that the Commission determines to be qualified by experience and character to act as an OTI. Further, no person may act as an OTI unless that person furnishes a bond, proof of insurance or other surety in a form and amount determined by the Commission to ensure financial responsibility. The Commission has implemented the provisions of section 19 in regulations VerDate Sep<11>2014 18:09 Feb 05, 2019 Jkt 247001 contained in 46 CFR part 515, including financial responsibility Forms FMC–48, FMC–67, FMC–68, and FMC–69, Optional Rider Forms FMC–48A and FMC–69A, its related license application Form, FMC–18, and the related foreign-based unlicensed NVOCC registration/renewal Form FMC–65. Current Actions: There are no changes to this information collection, and it is being submitted for extension purposes only. Type of Review: Extension. Needs and Uses: The Commission uses information obtained under this part and through Form FMC–18 to determine the qualifications of OTIs and their compliance with shipping statutes and regulations and to enable the Commission to discharge its duties under the Act by ensuring that OTIs maintain acceptable evidence of financial responsibility. If the collection of information were not conducted, there would be no basis upon which the Commission could determine if applicants are qualified for licensing. The Commission would also not be able to effectively assess the compliance of foreign-based unlicensed NVOCCs without the required registration information. Frequency: This information is collected when applicants apply for a license or registration, complete the triennial renewal, or when existing licensees or registrants change certain information in their application forms. Type of Respondents: The types of respondents are persons desiring to obtain or maintain a license or registration to act as an OTI. Under the Act, OTIs may be either an ocean freight forwarder, a non-vessel-operating common carrier, or both. Number of Annual Respondents: The Commission estimates a potential annual respondent universe of 6,475 entities. Estimated Time per Response: The time per response for completing application Form FMC–18 averages 2 hours and to complete the triennial renewal is 10 minutes. The time to complete a financial responsibility form averages 20 minutes. The time to complete Form FMC–65 to register or renew a registration as a foreign-based NVOCC averages 10 minutes. Total Annual Burden: The Commission estimates the total annual person-hour burden at 3,941 personhours. Rachel Dickon, Secretary. [FR Doc. 2019–01171 Filed 2–5–19; 8:45 am] BILLING CODE 6731–AA–P PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics; Notice of Charter Renewal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of charter renewal. AGENCY: This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Board of Scientific Counselors, National Center for Health Statistics, Department of Health and Human Services, has been renewed for a 2-year period through January 19, 2021. FOR FURTHER INFORMATION CONTACT: Sayheedha Uddin, M.D., M.P.H., Designated Federal Officer, Board of Scientific Counselors, National Center for Health Statistics, Department of Health and Human Services, 3311 Toledo Road, Room 2627, Mailstop P08, Hyattsville, Maryland 20782, telephone (301) 458–4303 or fax (301) 458–4020. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. SUMMARY: Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01208 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as E:\FR\FM\06FEN1.SGM 06FEN1 Federal Register / Vol. 84, No. 25 / Wednesday, February 6, 2019 / Notices patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)–RFA–TS–19–001, Identify, Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS). Date: April 24, 2019. Time: 11:00 a.m.–5:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (770) 488–6562, KLeeks@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01211 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention amozie on DSK3GDR082PROD with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) PAR13–129; Amended Notice of Meeting Notice is hereby given of a change in the name of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) PAR13–129; February 26, 2019, 12:00 p.m.–4:00 p.m., EST which was published in the Federal Register on December 21, 2018 Volume 83, Number 245, page 65675. The meeting is being amended to change the funding opportunity announcement to PAR18–812. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Nina Turner, Ph.D., Scientific Review Officer, Office of Extramural Programs, 1095 Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285–5976; Email: nxt2@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to VerDate Sep<11>2014 18:09 Feb 05, 2019 Jkt 247001 2227 announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Request for Nominations of Potential Reviewers To Serve on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) [FR Doc. 2019–01206 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Notice of request for nominations. ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)–DD19–002, The Muscular Dystrophy Surveillance, Tracking, and Research Network(MD STARnet). Dates: April 2–3, 2019. Times: 10:00 a.m.–6:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop 80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01210 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) in the National Center for Injury Prevention and Control (NCIPC), the National Center for Environmental Health (NCEH), and the Agency for Toxic Substances and Disease Registry (ATSDR). SUMMARY: Nominations for membership on the NCIPC, NCEH and ATSDR SEPs must be received no later than April 1, 2019. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to NCIPC Extramural Program Office (ERPO): Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop F–63, Atlanta, GA 30341, emailed (recommended) to NCIPC_PeerReview@cdc.gov, or faxed to (770) 488–4529. FOR FURTHER INFORMATION CONTACT: Kenneth Roberts, Public Health Analyst, CDC/NCIPC/ERPO, 4770 Buford Highway, Mailstop F–63, Atlanta, GA 30341; Telephone: (404) 498–1427; Email: KRoberts3@cdc.gov. SUPPLEMENTARY INFORMATION: The Disease, Disability, and Injury Prevention and Control Special Emphasis Panel provides advice and guidance to the Secretary, Department of Health and Human Services (HHS); the Director, Centers for Disease Control and Prevention (CDC), and the Administrator, Agency for Toxic Substances and Disease Registry (ATSDR) regarding the concept review, scientific and technical merit of grant and cooperative agreement assistance applications, and contract proposals relating to the causes, prevention, and control of diseases, disabilities, injuries, and impairments of public health significance; exposure to hazardous substances in the environment; health promotion and education; and other related activities that promote health and well-being. Nominations are being DATES: E:\FR\FM\06FEN1.SGM 06FEN1

Agencies

[Federal Register Volume 84, Number 25 (Wednesday, February 6, 2019)]
[Notices]
[Pages 2226-2227]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01211]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as

[[Page 2227]]

patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)-RFA-TS-19-001, Identify, 
Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral 
Sclerosis (ALS).
    Date: April 24, 2019.
    Time: 11:00 a.m.-5:00 p.m., EDT.
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., 
Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, 
Mailstop F-63, Atlanta, Georgia 30341, Telephone (770) 488-6562, 
KLeeks@cdc.gov.

    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal 
Register notices pertaining to announcements of meetings and other 
committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and 
Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01211 Filed 2-5-19; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.